• Home
  • News
  • Breast
  • Lung
  • Prostate
  • Colorectal
  • Stomach
  • Bone
  • Leukemia
  • Brain
  • Treatment
  • Other
    • Expert Opinions and Interviews
    • Prevention and Early Detection
Search
Logo
Logo
  • Home
  • News
  • Breast
  • Lung
  • Prostate
  • Colorectal
  • Stomach
  • Bone
  • Leukemia
  • Brain
  • Treatment
  • Other
    • Expert Opinions and Interviews
    • Prevention and Early Detection
Logo
Logo
HomeCancerResearch

For wholesome adults, taking multivitamins each day isn’t related to a decrease danger of dying

Research
July 6, 2024
61
0

Besremi Acknowledged by Up to date Pointers for Important Thrombocythemia

January 31, 2026

FDA Grants Orphan Drug Standing to CTD402 for Uncommon T-Cell Blood Cancers

January 31, 2026

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

January 31, 2026

Grieving After Most cancers: Recommendation for These Grieving and Supporting Them

January 31, 2026

Managing Vitamin Adjustments in Sufferers With Gastrointestinal Cancers

January 31, 2026


Media Advisory

Wednesday, June 26, 2024


Findings come from an NIH evaluation of greater than 20 years of dietary information from 390,124 U.S. adults.

What

A big evaluation of information from almost 400,000 wholesome U.S. adults adopted for greater than 20 years has discovered no affiliation between common multivitamin use and decrease danger of dying. The research, led by researchers on the Nationwide Institutes of Well being’s Nationwide Most cancers Institute, was printed June 26, 2024, in JAMA Community Open.

Many adults in the US take multivitamins with the hope of enhancing their well being. Nonetheless, the advantages and harms of standard multivitamin use stay unclear. Earlier research of multivitamin use and mortality have yielded blended outcomes and been restricted by quick follow-up occasions.

To extra deeply discover the connection between long-term common multivitamin use and total mortality and dying from heart problems and most cancers, the researchers analyzed information from three massive, geographically numerous potential research involving a complete of 390,124 U.S. adults who have been adopted for greater than 20 years. The individuals included on this evaluation have been typically wholesome, with no historical past of most cancers or different persistent illnesses.

As a result of the research inhabitants was so massive and included prolonged follow-up and intensive data on demographics and way of life elements, the researchers have been in a position to mitigate the consequences of doable biases which will have influenced the findings of different research. For instance, individuals who use multivitamins could have more healthy life basically, and sicker sufferers could also be extra prone to enhance their use of multivitamins.

The evaluation confirmed that individuals who took each day multivitamins didn’t have a decrease danger of dying from any trigger than individuals who took no multivitamins. There have been additionally no variations in mortality from most cancers, coronary heart illness, or cerebrovascular illnesses. The outcomes have been adjusted for elements equivalent to race and ethnicity, training, and weight loss plan high quality. 

The researchers famous that you will need to consider multivitamin use and danger of dying amongst completely different sorts of populations, equivalent to these with documented dietary deficiencies, in addition to the potential impression of standard multivitamin use on different well being circumstances related to growing old.

Who

Erikka Loftfield, Ph.D., M.P.H., Division of Most cancers Epidemiology and Genetics, Nationwide Most cancers Institute

Examine

 “Multivitamin Use and Mortality Threat in 3 Potential US Cohorts” seems June 26, 2024, in JAMA Community Open.

In regards to the Nationwide Most cancers Institute (NCI): NCI leads the Nationwide Most cancers Program and NIH’s efforts to dramatically scale back the prevalence of most cancers and enhance the lives of individuals with most cancers. NCI helps a variety of most cancers analysis and coaching extramurally by way of grants and contracts. NCI’s intramural analysis program conducts revolutionary, transdisciplinary fundamental, translational, medical, and epidemiological analysis on the causes of most cancers, avenues for prevention, danger prediction, early detection, and remedy, together with analysis on the NIH Medical Heart—the world’s largest analysis hospital. Be taught extra concerning the intramural analysis achieved in NCI’s Division of Most cancers Epidemiology and Genetics. For extra details about most cancers, please go to the NCI web site at most cancers.gov or name NCI’s contact middle at 1-800-4-CANCER (1-800-422-6237).

In regards to the Nationwide Institutes of Well being (NIH):
NIH, the nation’s medical analysis company, contains 27 Institutes and Facilities and is a part of the U.S. Division of Well being and Human Companies. NIH is the first federal company conducting and supporting fundamental, medical, and translational medical analysis, and is investigating the causes, therapies, and cures for each widespread and uncommon illnesses. For extra details about NIH and its packages, go to www.nih.gov.

NIH…Turning Discovery Into Well being®

###

Share
Facebook
Twitter
Pinterest
WhatsApp
    Previous article
    Deep learning-based cross-classifications reveal conserved spatial behaviors inside tumor histological pictures
    Next article
    Nice-Grandmother Wins $5 Million Lottery

    Hot Topics

    Besremi Acknowledged by Up to date Pointers for Important Thrombocythemia

    FDA Grants Orphan Drug Standing to CTD402 for Uncommon T-Cell Blood Cancers

    Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

    Load more

    Related Articles

    Editor - January 31, 2026

    Besremi Acknowledged by Up to date Pointers for Important Thrombocythemia

    Editor - January 31, 2026

    FDA Grants Orphan Drug Standing to CTD402 for Uncommon T-Cell Blood Cancers

    Editor - January 31, 2026

    Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

    Load more
    Logo
    Facebook
    Twitter
    Youtube

    Quick Links

    • Home
    • News
    • Breast
    • Lung
    • Prostate
    • Colorectal
    • Stomach
    • Bone
    • Leukemia
    • Brain
    • Treatment
    • Other
      • Expert Opinions and Interviews
      • Prevention and Early Detection

    Must Read

    Besremi Acknowledged by Up to date Pointers for Important Thrombocythemia

    FDA Grants Orphan Drug Standing to CTD402 for Uncommon T-Cell Blood Cancers

    Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

    Grieving After Most cancers: Recommendation for These Grieving and Supporting Them

    Popular Articles

    Besremi Acknowledged by Up to date Pointers for Important Thrombocythemia

    FDA Grants Orphan Drug Standing to CTD402 for Uncommon T-Cell Blood Cancers

    Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

    © 2024 Cancer Care Portal. All rights reserved.